The sleep-wake disorder is a sign of an impending condition such as bipolar disorder. Sleep disorders range from insomnia disorder to narcolepsy and breathing-related disorder to restless leg syndrome. These disorders are diagnosed through comprehensive assessment, which entails a detailed patient history, questionnaires and sleep diaries, physical exam, and clinical testing. Moreover, these disorders are often addressed in similar comprehensive ways including pharmacologic, behavioral, and other treatments, and therapies combined with medical care.

The transition towards a sedentary lifestyle with increasing usage of gadgets such as laptops and smartphone has significantly increased the instances of sleep-wake disorders across the globe. According to the America Academy of Sleep Medicine, in the US, around 30 million people were suffering from sleep-wake disorders in 2015; among which, 21% of women were suffering from sleep apnea in the country. Therefore, the rising trend of sleep-wake disorders is propelling the development of innovative therapies, medications, and devices in the market.

The global sleep-wake disorder market is segmented on the basis of type and treatment. On the basis of type, the market is diversified into insomnia, hypersomnia (narcolepsy and insufficient sleep syndrome), sleep apnea, circadian rhythm disorders, and others such as parasomnia. On the basis of treatment, the market is further sub-segmented into therapies (cognitive behavioral therapy), medications (herbal drugs and others), and devices such as sleep apnea devices.

The global sleep-wake disorder market is further analyzed on the basis of geographical regions, including North America, Europe, Asia-Pacific, and Rest of the World. North America contributed the largest share in the global sleep-wake disorder market in 2018. This is mainly attributed to a rising sedentary lifestyle and significant presence of geriatric population in the region. According to the National Highway Traffic Safety Administration, in 2015, around 100,000 vehicle accidents occur every year due to drowsy driving. Therefore, the increasing prevalence of sleep-wake disorder offers a growth factor for the North America sleep-wake disorder market. Furthermore, Asia-Pacific region is projected to exhibit the fastest growth in the global sleep-wake disorder market during the forecast period. Rising prevalence of sleep disorders among young people in the emerging economies of the region, particularly in China, is significantly propelling the market growth in Asia-Pacific.

Some of the players operating in the global sleep-wake disorder market include Jazz Pharmaceuticals, Inc., Koninklijke Philips N.V., Merck KGaA, Neurocrine Biosciences, Inc., RespireRx Pharmaceuticals Inc., Medtronic PLC, Teva Pharmaceutical Industries Ltd., and Vanda Pharmaceuticals Inc. The companies are focused on the development of innovative products for sleep-wake disorder market to stay competitive in the global market. Market players adopt various strategies such as geographical expansion, merger and acquisition, partnerships, and collaborations are expected to expand individual market share are some of the key strategies adopted by major market players. Furthermore, the rapid prevalence of sleep apnea has gained the traction of drug development companies and researchers across the globe. For instance, in April 2019, the researchers at the University of Lowa have revealed a link between multiple myeloma and sleep apnea, that can significantly lead to the earlier and effective treatment of the disease.

Research Methodology:

The market study of the global sleep-wake disorder market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog

The report is intended for healthcare providers, research organizations, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Sleep-Wake Disorder Market Research and Analysis by Type
2. Global Sleep-Wake Disorder Market Research and Analysis by Treatment

The Report Covers:

• Comprehensive research methodology of the global sleep-wake disorder market.
• This report includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global sleep-wake disorder market.
• Insights about market determinants which are stimulating the global sleep-wake disorder market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.